Background: Hypertrophic cardiomyopathy (HCM) is a complex and heterogeneous cardiovascular disease, the pathogenesis of which remains unclear. In this study, we aimed to explore potential biomarkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback